Clinical Trial

Comparison of 90° and 120° Arm Positions in Costoclavicular Block

Study acronym: COSTO-RCT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 9, 2026 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The costoclavicular approach of the infraclavicular brachial plexus block is widely used for upper extremity surgeries due to its reliable anatomy and high success rates. Patient positioning, particularly the degree of arm abduction, may influence the spread of local anesthetic and the characteristics of the block. However, the optimal arm abduction angle during this procedure remains unclear. This prospective randomized controlled trial aims to investigate the effect of two different arm abduction angles (90° and 120°) on block onset time and block success in patients undergoing hand, wrist, and forearm surgery under ultrasound-guided costoclavicular brachial plexus block. Patients will be randomly assigned to one of two groups according to the degree of arm abduction. The primary outcome is block onset time. Secondary outcomes include block success, sensory and motor block characteristics, perfusion index changes, hemodynamic parameters, readiness for surgery at 15 and 20 minutes, block performance time, need for additional anesthesia, postoperative neurological evaluation at 4 and 24 hours, complications, and patient satisfaction. The findings of this study are expected to provide evidence on optimal patient positioning to improve the effectiveness and reliability of ultrasound-guided costoclavicular brachial plexus block.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-05-08; most recent amendment 2026-06-06.
Trial Details
NCT Number NCT07586670
Lead Sponsor Ankara Etlik City Hospital
Conditions Perfusion Index, Upper Extremity Surgery, Brachial Plexus Block, Regional Anaesthesia
Enrollment 106 participants
Start Date 2026-05-15
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-08-27 (estimated)
Updated on ClinicalTrials.gov 2026-06-09